Enable Injections and Serina Therapeutics Announce Agreement to Develop SER-252 in Combination with enFuse® for Advanced Parkinson’s Disease

Published By :
May 15, 2024
email icon in blackFacebook icon in blacktwitter icon in blackLinkedIn icon in black
gradient colors in orange, pink and purple

Recent News & Insights

Tembo capitalizes on the database boom and lands new cash to expand

Featured News
·
July 8, 2024

Announcing Tembo Series A

Featured News
·
July 3, 2024

Airway Therapeutics Wins 2024 ATS Whitsett Award

Featured News
·
June 24, 2024
More News And Insights
Subscribe TO our newsletter

Stay Up To Date With Our News & Insights

Stay informed with current news about our portfolio companies, events and industry insights.
email icon in gradient orange, pink and purple colors
You are subscribed to our newsletters
Oops! Something went wrong while submitting the form.
CincyTech is a venture capital firm that invests in innovative founders tackling the world's complex challenges. Our experienced team is fluent in the language of founders, researchers, and inventors working with deep domain expertise and market foresight. We partner early to help transform ideas into world-class companies.
2900 Reading Rd. Ste. 410 Cincinnati, OH 45206
Contact CincyTech
Twitter icon in white
Cincytech logo
HomeApproachPortfolioTeamCommunityNews & InsightsPitch Us
© 2023 Copyright - CincyTech
CareersUniversity ProgramsDisclosures
Made by 5Four Digital®